MODIFIED STAGE-I (T1NOM0, T2NOM0), NONSMALL CELL LUNG-CANCER - TREATMENT RESULTS, RECURRENCE PATTERNS, AND ADJUVANT IMMUNOTHERAPY

被引:0
|
作者
LITTLE, AG
DEMEESTER, TR
FERGUSON, MK
SKINNER, DB
HOFFMAN, PC
SKOSEY, C
BLOUGH, RR
GOLOMB, HM
机构
[1] UNIV CHICAGO,CTR MED,DEPT MED,CHICAGO,IL 60637
[2] UNIV CHICAGO,CTR MED,BIOMED COMPUTAT FACILITIES,CHICAGO,IL 60637
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:621 / 628
页数:8
相关论文
共 50 条
  • [31] BLOOD-VESSEL INVASION BY TUMOR-CELLS PREDICTS RECURRENCE IN COMPLETELY RESECTED T1-N0-M0 NON-SMALL-CELL LUNG-CANCER
    MACCHIARINI, P
    FONTANINI, G
    HARDIN, MJ
    CHUANCHIEH, H
    BIGINI, D
    VIGNATI, S
    PINGITORE, R
    ANGELETTI, CA
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (01): : 80 - 89
  • [32] The evolving landscape of adjuvant therapy in T1-T2N0 resected non-small cell lung cancer: a narrative review
    Zolfaghari, Emily June
    Dhanasopon, Andrew
    Woodard, Gavitt A.
    JOURNAL OF THORACIC DISEASE, 2024, 16 (12) : 8815 - 8822
  • [33] Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer, stage II in 7th TNM but stage I in 6th TNM system?
    Lee, H. J.
    Lee, K. G.
    Suh, Y. S.
    Kong, S. H.
    Oh, D. Y.
    Im, S. A.
    Bang, Y. J.
    Yang, H. K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S424 - S424
  • [34] Clinical Results of Stereotactic Body Radiation Therapy (SBRT) for Stage IB (T2aN0M0) Non-Small Cell Lung Cancer (NSCLC)
    Hashizume, C.
    Shibamoto, Y.
    Tsugawa, T.
    Otsuka, S.
    Hayashi, A.
    Takaoka, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E420 - E420
  • [35] Time-Varying Pattern of Postoperative Recurrence Risk of Early-Stage (T1a-T2bN0M0) Non-Small Cell Lung Cancer (NSCLC): Results of a Single-Center Study of 994 Chinese Patients
    Zhu, Jian-fei
    Feng, Xing-yu
    Zhang, Xue-wen
    Wen, Ying-sheng
    Lin, Peng
    Rong, Tie-hua
    Cai, Ling
    Zhang, Lan-jun
    PLOS ONE, 2014, 9 (09):
  • [36] Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients
    Berry, Mark F.
    Coleman, Brooke K.
    Curtis, Lesley H.
    Worni, Mathias
    D'Amico, Thomas A.
    Akushevich, Igor
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (02) : 642 - 648
  • [37] Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients
    Mark F. Berry
    Brooke K. Coleman
    Lesley H. Curtis
    Mathias Worni
    Thomas A. D’Amico
    Igor Akushevich
    Annals of Surgical Oncology, 2015, 22 : 642 - 648
  • [38] Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
    Kyung-Goo Lee
    Hyuk-Joon Lee
    Seung-Young Oh
    Jun-Young Yang
    Hye-Seong Ahn
    Yun-Suhk Suh
    Seong-Ho Kong
    Tae-Yong Kim
    Do-Youn Oh
    Seock-Ah Im
    Kuhn Uk Lee
    Woo Ho Kim
    Yung-Jue Bang
    Han-Kwang Yang
    Annals of Surgical Oncology, 2016, 23 : 1234 - 1243
  • [39] Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
    Lee, Kyung-Goo
    Lee, Hyuk-Joon
    Oh, Seung-Young
    Yang, Jun-Young
    Ahn, Hye-Seong
    Suh, Yun-Suhk
    Kong, Seong-Ho
    Kim, Tae-Yong
    Oh, Do-Youn
    Im, Seock-Ah
    Lee, Kuhn Uk
    Kim, Woo Ho
    Bang, Yung-Jue
    Yang, Han-Kwang
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (04) : 1234 - 1243
  • [40] Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer
    Slotman, BJ
    Antonisse, IE
    Njo, KH
    RADIOTHERAPY AND ONCOLOGY, 1996, 41 (01) : 41 - 44